Related Experiment Video
Updated: Jun 17, 2026

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome
Andrea Borini1, Paolo Emanuele Levi Setti, Paola Anserini
1Tecnobios Procreazione, Centre for Reproductive Health, Bologna, Italy. borini@tecnobiosprocreazione.it
Fertility and Sterility
|January 6, 2010
Summary
Oocyte cryopreservation using slow-cooling with sucrose shows reduced clinical outcomes compared to fresh cycles. However, it remains a viable option for patients with surplus oocytes when embryo cryopreservation is not feasible.
Area of Science:
- Reproductive Medicine
- Assisted Reproductive Technology
Background:
- Oocyte cryopreservation offers fertility preservation but its clinical efficacy requires evaluation.
- Slow-cooling protocols are commonly used, with sucrose as a cryoprotective agent.
Purpose of the Study:
- To assess the effectiveness of a specific slow-cooling oocyte cryopreservation protocol using sucrose.
- To compare clinical outcomes of frozen-thawed oocytes with fresh oocytes in in vitro fertilization (IVF) cycles.
Main Methods:
- An observational study comparing fresh and frozen-thawed oocyte cycles in infertile couples undergoing IVF.
- A standardized slow-cooling protocol with 0.2 mol/L sucrose was employed for cryopreservation.
- Maximum of three oocytes were used per cycle, with all thawed oocytes being microinjected.
Main Results:
- A total of 2,209 oocyte cryopreservations were performed, with a 55.8% survival rate for thawed oocytes.
- Frozen-thawed oocyte cycles showed significantly lower fertilization, implantation, and pregnancy rates compared to fresh cycles.
- Despite reduced rates, most clinics achieved a pregnancy rate per thawing cycle above 14%.
Conclusions:
- Oocyte slow-cooling cryopreservation with sucrose results in diminished clinical outcomes relative to fresh cycles.
- Oocyte cryopreservation is a recommended option for patients with surplus oocytes when embryo cryopreservation is not applicable.
